Aug. 1, 0201

 Kalipso Chalkidou represented NICE International at a WHO-convened meeting on Health Technology Assessment at the Geneva HQ of WHO.  Representatives from across WHO and institutions from high and low and middle income countries from around the world discussed progress towards the World Health Assembly Resolution on Health Intervention and Technology Assessment (HITAP) and plans for enhancing the role of WHO in offering technical and process guidance for supporting HTA initiatives. The NICE International Director presented an overview of iDSI.

Workshop Agenda 2-3 November 2015

 NICE International at the Brocher Foundation workshop

NICE International was invited to join a group of academics, practitioners and policy makers from around the world, in the fields of Law, Ethics, Philosophy, Political Science, Public Health, HTA and Patient and Public Involvement, with the aim of:

  • Learning more about patient and public involvement in health prioritisation decisions in different countries in practice and in research.
  • Presenting the initial results of research on a draft decision making audit tool (DMAT) to support patient and public involvement in health prioritisation and to further refine it in order to make it suitable for international testing and use.
  •  Publishing an account of the workshop in suitable formats (special edition of Journal of Health Organization and Management).

The Workshop offered the chance to discuss the ethics stream of iDSI and plan for the forthcoming submission for a Wellcome Trust grant for researching the ethical values underpinning priority setting decisions in health. The outcomes of the workshop will be written up in a series of papers for a special edition of the Journal of Health Organization and Management.


May 2014

At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on “Health intervention and technology assessment in support of universal health coverage”. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role of priority-setting in universal health coverage, alongside counterparts from Thailand, Iran, Ethiopia and the World Health Organisation.  The resolution called on Member States to develop and strengthen national and regional capacities for priority-setting, and for the WHO to support these efforts.  WHO Director General, Dr Margaret Chan, attended the session and made supportive remarks about the work of NICE, which was named as a “resource organisation” for health technology assessment.

Prof Haslam, describing NICE’s role in making decisions on behalf of the NHS in consideration of social values and best available evidence on cost-effectiveness, said: “Every pound can only be spent once. If we spend it unwisely, on costs that cannot be justified, then we risk harming other people whose care will be adversely affected.” And with all health systems facing fundamentally similar challenges, “It is vital that priority setting is an evidence-informed, procedurally fair process that defines what will be covered through universal health coverage.”

The WHO is a key partner for iDSI and NICE International: “Our approach aligns closely with the draft resolution on health intervention and technology assessment in support of universal health coverage. We are committed to working with WHO, the regional and country offices to make the resolution a reality around the globe.”

Prof Haslam thanked the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Rockefeller Foundation for supporting the international Decision Support Initiative (iDSI), a multidisciplinary platform led by NICE International and which aims to help low- and middle-income countries achieve universal health coverage through active priority-setting. Closing his speech, Prof Haslam said: “The use of evidence help us make judicious choices that in turn can make huge differences to millions of people globally. People we will never meet, but who deserve to reap the benefits of medical science.”